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Purpose: Due to the shortcomings of nanocarriers, the development of carrier-free nano-
delivery systems has attracted more and more attention in cancer treatment. However, there 
are few studies on carrier-free nanosystems that can simultaneously achieve monitoring 
functions. Here a multifunctional carrier-free nanosystem loaded with curcumin and irinote-
can hydrochloride was established for the treatment and monitoring of gastric cancer.
Methods: In this study, an irinotecan hydrochloride-curcumin nanosystem in the early stage 
(the system is named SICN) was prepared. Based on the fluorescence of curcumin, flow 
cytometry, laser confocal microscopy, and zebrafish fluorescence imaging were used to study 
the monitoring function of SICN in vivo and in vitro. In addition, HGC-27 human gastric 
cancer cells were used to study SICN cytotoxicity.
Results: Flow cytometry and zebrafish fluorescence imaging monitoring results showed that 
the uptake of SICN was significantly higher than free curcumin, and the excretion rate was 
lower. SICN had higher accumulation and retention in cells and zebrafish. Laser confocal 
microscopy monitoring results showed that SICN was internalized into HGC-27 cells 
through multiple pathways, including macropinocytosis, caveolin, and clathrin-mediated 
and clathrin -independent endocytosis, and distributed intracellularly throughout the whole 
cytoplasm, including lysosomes and Golgi apparatus. In vitro cell experiments showed that 
SICN nanoparticles were more toxic than single components, and HGC-27 cells had more 
absorption and higher toxicity to nanoparticles under slightly acidic conditions.
Conclusion: SICN is a promising carrier-free nanoparticle, and the combination of two 
single-component therapies can exert a synergistic antitumor effect. When exposed to 
a tumor acidic environment, SICN showed stronger cytotoxicity due to charge conversion. 
More importantly, the nanoparticles’ self-monitoring function has been developed, opening 
up new ideas for combined tumor therapy.
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Introduction
Cancer is a major public health problem worldwide1 and second to cardiovascular 
disease in threatening human life.2 There has been huge progress in cancer treatment, 
including surgery, radiotherapy, chemotherapy, and immunotherapy.3–5 Chemotherapy 
remains the most common therapeutic modality due to its high efficiency. However, 
clinical trials have proven that chemotherapy has many problems, such as poor target-
ing, systemic effects, and indiscriminate destruction of normal cells, resulting in 
various side effects.6,7 In recent years, targeted cancer therapy based on nanoplatforms 
has expanded tremendously,8 which greatly enhanced targeting,9 improved efficacy, 
and reduced side effects.10 Nevertheless, the fabrication of targeting nanocarriers is 
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complicated, and nanocarriers may also have the risk of poor 
stability, nondegradability, and long-term toxicity.11 Only 
a few nanodrugs have been approved for clinical use.12 
Therefore, it is more attractive to develop a targeted, carrier- 
free nanodelivery system.
Nanodrugs need to overcome a series of barriers 
(circulation, accumulation, penetration, internalization, 
and release)13 to affect solid tumors. In other words, 
the amount of nanomedicine that can be effectively 
delivered to tumors and absorbed by tumor cells is pretty 
small, leading to a significant reduction in bioavailabil-
ity. Previous studies have shown that the use of nano-
particle therapeutic media to respond to external stimuli 
(such as light,14 pH,15 enzymes,16 magnetic field,17 and 
temperature18) can significantly improve antitumor effi-
cacy. Quan et al designed a nanomedicine that responds 
to the highly expressed γ-glutamyl transpeptidase on the 
tumor cell surface, which can achieve high uptake and 
infiltration of distal tumor cells from the blood vessels.13 
Consequently, it is interesting to utilize the tumor micro-
environment or tumor heterogeneity to enhance drug 
uptake and penetration.
Besides improving therapeutic efficacy with nanotech-
nology, it is also highly desirable to simultaneously achieve 
real-time monitoring of the uptake and release or distribution 
of drug molecules within the nanosystem in vivo and vitro. 
So far, an effective and prevalent strategy for achieving 
monitoring is to encapsulate chemotherapeutic drugs into 
fluorescent nanomaterials of inert carriers or construct nano-
particles with drugs and fluorescent markers.19–21 
Nevertheless, the preparation of nanocarriers is not easy 
and may have potential toxicity. The low drug loading caused 
by carriers or fluorescent markers severely limits the applica-
tion of multifunctional therapy.22 Therefore, it is necessary to 
utilize therapeutic and nontoxic, fluorescent small-molecule, 
and chemotherapeutic drugs to construct a multifunctional 
nanodelivery system that can simultaneously realize self- 
monitoring, improve curative effects, and reduce side effects.
Given these challenges, a carrier-free drug self-delivery 
system was developed based on a molecular structure that is 
easy to construct and can respond to pH. In our previous 
research, a drug self-delivery system of camptothecin deriva-
tives and curcumin was constructed, and it has been proven to 
be effective against colon cancer. The severe clinical diarrhea 
effect of irinotecan is greatly reduced due to the change in 
targeting.23 However, as a fluorescent small-molecule drug, 
curcumin has not been fully developed for its self-monitoring 
function. In this study, a carrier-free, self-assembly strategy 
was used again to prepare multifunctional nanoparticles of 
curcumin and camptothecin derivatives by precipitation. Self- 
assembled nanoparticles can significantly improve the antic-
ancer effect of gastric cancer cells. Meanwhile, their adjustable 
surface charge in a slightly acidic tumor environment greatly 
enhances the nanoparticles’ uptake and anticancer activity. 
More importantly, based on the fluorescence of curcumin, 
nanoparticles can be used to monitor the absorption and uptake 
of gastric cancer cells and zebrafish in real-time, as well as to 
further explore the internalization and transport pathways of 
nanoparticles (Figure 1). In addition, curcumin has high bio-
logical safety and broad antitumor activity24,25 and can be used 




Irinotecan hydrochloride, curcumin, poloxamer 105, manni-
tol, and dimethyl sulfoxide (DMSO) were purchased from 
Sigma-Aldrich and used as received (USA). Dulbecco’s 
modified Eagle’s medium (DMEM; pH 7.5) and HQ fetal 
bovine serum (FBS) were purchased from TransGen Biotech 
Co., Ltd. (Beijing, China). Wortmannin, cytochalasin D, 
genistein, and methyl-β-cyclodextrin were purchased from 
Meilun Biotechnology Co., Ltd. (Dalian, China). 
Chlorpromazine was obtained from Selleck Chemicals 
(Shanghai, China). Hydrochloric acid was purchased from 
Chengdu Kelong Chemical Reagent Factory (Chengdu, 
China). Phosphate-buffered saline (PBS; pH 7.4) was pre-
pared in the laboratory, and ultrapure water was produced 
using a Milli-Q integral water purification system.
Preparation of SICN Nanoparticle
SICN Nanoparticles was have been prepared by precipitation 
method in our previous paper.23 In brief, Irinotecan hydro-
chloride (6.2 mg) and curcumin (3.7 mg) (molar ratio 1:1) 
were dissolved in dimethyl sulfoxide (DMSO, 300 μL), and 
0.5 mg of non-ionic surfactant poloxamer 105 was added. The 
suspension was obtained by adding ultra pure water (30 mL) 
into DMSO solvent under magnetic stirring, and then the 
organic solvent was removed by dialysis. Nanoparticle powder 
was obtained after lyophilization with mannitol.
Characterization of SICN NPs
The particle size in different solvents at room temperature 
were measured by Nicomp 380 ZL S Laser Particle Size 
Analyzer (PSS, USA). Scanning electron microscopy (SEM) 
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and transmission electron microscopy (TEM) were used to 
observe the morphology and structure of nanoparticles. The 
diffraction behavior of nanoparticles were characterized by 
a Bruker X-Ray Diffraction Analyzer (XRD, Bruker, 
Germany). Multifunctional microplate reader SpectraMax- 
i3 (Molecular Devices, America) was applied for exploring 
the drug release and fluorescence change.
Cell Culture
HGC-27 cell lines were purchased Procell Life 
Science&Technology Co., Ltd. (No: 8200F031002) and 
were incubated in DMEM supplemented with 10% 
TransSerumTM HQ FBS and 1% penicillin-streptomycin 
at 37°C at a humidified atmosphere containing 5% CO2.
In vitro Cellular Uptake and Release of 
SICN
Cellular uptake and release by HGC-27 cells were per-
formed using flow cytometry. HGC-27 cells were seeded 
in 12-well plates at 1 × 105 cells/well and treated with 
SICN and curcumin (12.5 μM/L). At designated time 
intervals, cells were harvested after trypsinization and 
centrifuged at 1500 rpm for 5 min. Subsequently, the cell 
pellets were resuspended in 1 mL of 1× PBS. Flow 
cytometry was done using a BD FACSVerse flow cyt-
ometer (BD Biosciences).
Cellular Uptake and Release of SICN in 
Zebrafish
AB strain zebrafish was supported by the zebrafish 
experimental platform at Chengdu University of 
Traditional Chinese Medicine (Chengdu, China), which 
was approved by the Ethics Review Committee of 
Chengdu University of Traditional Chinese Medicine 
(Ethics review record number:2018-16). The use of zeb-
rafish follows Laboratory animal-Biosafety requirement 
laboratory animal experiment (T/CALAS7-2017) pro-
mulgated by the Chinese Society of Laboratory 
Animals. Zebrafish husbandry and breeding were per-
formed according to the zebrafish book standards.26 
Adult zebrafish were maintained at 28.5°C under a 14 
h light/10 h dark cycle in fish water (pH 7.2–7.5 and 
conductivity 500–550 μs/cm). Zebrafish embryos were 
obtained from adults segregated by sex and mated in 
tanks overnight. Spawning was induced in the next light 
cycle when the light was turned on. Embryos were incu-
bated at 28.5°C, and larvae at 5 days postfertilization 
were incubated with 12.5 μM/L SICN and curcumin. At 
designated time intervals, each larva’s fluorescence was 
Figure 1 Application of self-monitoring function of self-assembled SICN nanoparticles based on the fluorescence of curcumin.
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observed, and larvae were photographed immediately 
with a Leica fluorescence microscope. Simultaneously, 
to observe SICN excretion in vivo, the medicine was 
replaced with fresh fish-water after 4 h administration 
and imaged.
Endocytosis and Intracellular Transport of 
SICN Nanoparticles
HGC-27 cells were seeded on 35 mm glass-bottomed cul-
ture dishes and incubated at 37°C, 5% CO2 for 12 h. After 
removing the original medium, 1 mL DMEM (with 1% FBS 
and 1% penicillin-streptomycin) containing predetermined 
concentrations of chlorpromazine, genistein, methyl-β- 
cyclodextrin, wortmannin, and cytochalasin D was added 
to the culture dishes or placed in the dishes at a 4°C envir-
onment. After incubation for 0.5 h, the medium was 
removed, and SICN (6.25 μM/L) was added to each culture 
dish to continue incubation for 2 h. The 4°C group was 
maintained at 4°C. Before imaging, the culture dishes were 
washed thoroughly with ice-cold PBS. Finally, the fluores-
cent images of cells were recorded with a confocal laser 
scanning microscope (CLSM; Leica), and the fluorescence 
intensity of cells was measured at the same time.
To further study the intracellular transport pathway of 
SICN, HGC-27 cells were incubated with SICN for 6 h and 
then stained with LysoTracker Red and Golgi-Tracker Red 
(Beyotime Biotechnology). The staining process was per-
formed according to the manufacturer’s instructions. 
ProLong™ Live Antifade Reagent (Thermo Fisher 
Scientific) was added before observation with CLSM.
Cell Cytotoxicity Assay
HGC-27 cells were seeded on 96-well plates in DMEM 
containing 10% FBS and 1% penicillin-streptomycin and 
continued to culture for 24 h. After removing the original 
medium in each well, 100 μL DMEM (with 1% FBS and 
1% penicillin-streptomycin) containing predetermined 
concentrations of irinotecan hydrochloride, curcumin, and 
SICN were added to the designated wells. After a further 
culture for 48 h, the original culture medium was removed 
before adding the mixture containing 90 μL DMEM (with 
1% FBS and 1% penicillin-streptomycin) and 10 μL 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) stock solution (5 mg/mL in PBS) and incu-
bated for 4 h. Then, the medium containing MTT was 
completely removed, followed by the addition of 150 μL 
DMSO to each well. Cell viabilities were determined by 
reading the absorbance at 490 nm using Gen5 microplate 
reader and imager software (BioTek). Cells incubated with 
1% serum-supplemented medium represented 100% cell 
survival. Six replicate wells were run for each 
concentration.
Cell Apoptosis Assay
Apoptosis in cells was visualized using a KeyGen Annexin 
V-fluorescein isothiocyanate (FITC) Apoptosis Detection 
Kit. HGC-27 cells were placed in a 12-well plate at 
a density of 1 × 105 cells per well and further incubated 
for 24 h. Apoptosis in cells was induced by treating cells 
with curcumin, irinotecan hydrochloride, or SICN nano-
particles at 3.125 μM/L concentration for 48 h. Negative 
control was prepared by incubating cells in the absence of 
an inducing agent. Cells were harvested, washed twice 
with cold PBS, and stained with KeyGen Annexin V and 
propidium iodide (PI) according to the manufacturer’s 
instructions. Stained cells were analyzed by a BD 
FACSVerse flow cytometer.
Cell Cycle Assay
Cycle in cells was visualized using a MultiSciences Cell 
Cycle Staining Kit. HGC-27 cells were placed in a 12-well 
plate at a density of 1 × 105 cells per well and further 
incubated for 24 h and treated with curcumin, irinotecan 
hydrochloride, or SICN nanoparticles at 3.125 μM/L con-
centration for 48 h. Negative control was prepared by 
incubating cells in a medium without any drugs. Cells 
were harvested, washed twice with cold PBS, and stained 
with MultiSciences Cell Cycle agents according to the 
manufacturer’s instructions. Stained cells were analyzed 
by a BD FACSVerse flow cytometer.
Results and Discussion
Characterization of SICN NPs
Stabilized Particle Sizes
The SICN nanoparticles prepared by a simple precipitation 
method have good water solubility and are easily soluble 
in water and acid water. The measured particle sizes of 
SICN in water and acid water are 61.5±0.22 nm and 50 
±0.24 nm, respectively (Figure S1). It can be seen that 
there is little difference in the particle size of SICN in 
different acid-base solutions, and it is reasonable to infer 
that SICN nanoparticles are not easily affected by the 
acidic environment in solid tumors.
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Morphology and Appearance
The appearance and shape of SICN were observed under 
scanning electron microscope (SEM), as shown in Figure S2. 
SICN showed the shape of spherical particles, which exist 
individually or aggregated together. The results of transmission 
electron microscope (TEM) also showed that SICN was sphe-
rical nanoparticles (Figure S3), which was consistent with the 
results of SEM.
XRD Analysis
The XRD analysis of SICN and its components is shown 
in Figure S4 (scanning range of 5–50◦). Compared with 
irinotecan and curcumin, SICN has new diffraction peaks 
in many places, which means that a new crystal is formed.
The Drug Release and Fluorescence Change
The fluorescence change of SICN in the aqueous solution is 
shown in Figure S5B. In general, the fluorescence gradually 
increased within 36 hours and then decreased. There is 
almost no difference in the maximum fluorescence value in 
the range of 4–24h (p>0.05). According to the fluorescence 
emission curve, the maximum emission wavelength of irino-
tecan is 440nm, and the maximum emission wavelength of 
curcumin is 540nm (Figure S5A). We believe that the change 
in fluorescence at 440nm is caused by the release of irinote-
can. It can be seen that the release of irinotecan gradually 
increased within 36h (no significant difference between 4– 
24h (P>0.05), then the drug release slowed down and the 
fluorescence began to weaken due to the fluorescence 
quenching effect. The release and fluorescence changes of 
SICN in PBS solution are consistent with those in aqueous 
solution (Figure S5C). It shows that SICN exhibits the same 
drug release and fluorescence change behavior in different 
solvents. The difference is that the release in water is faster 
than in PBS solution (the fluorescence intensity of SICN in 
aqueous solution is always higher than in PBS solution).
Uptake and Release of SICN in Cells
Flow cytometry studies compared the uptake and release 
of SICN nanoparticles and free curcumin. As shown in 
Figure 2A and B, the control experiment in HGC-27 cells 
incubated without SICN/curcumin showed a much weaker 
fluorescence signal. In the first 4 h, the fluorescence of 
SICN nanoparticles and curcumin increased with incuba-
tion time, indicating that both SICN nanoparticles and 
curcumin can be absorbed by HGC-27 cells. Moreover, 
the uptake of SICN nanoparticles was significantly higher 
than free curcumin. Quantitative data in flow cytometry 
analysis are shown in Figure 2E, exhibiting that the fluor-
escence signals of SICN and free curcumin are weakened 
after 4 h. This may be due to the drug being released in or 
discharged from the cell. SICN fluorescence signals 
decreased steadily and slowly within 48 h, whereas free 
curcumin continuously decreased significantly, which is 
one reason for the low bioavailability of curcumin. 
Therefore, SICN nanoparticles are released and discharged 
slowly and steadily in the cell. It means that the nanoplat-
form can control the release of drugs, improve bioavail-
ability, help achieve long-term efficacy, and reduce the 
number of administrations.
To further compare the two drugs’ intracellular excre-
tion rate, flow cytometry was used to monitor the fluores-
cence intensity of SICN/curcumin after co-incubation with 
cells in real-time (after 4 h co-incubation, the drug- 
containing medium was replaced with fresh medium and 
marked as 0 h). As shown in Figure 2C and D, the excre-
tion rate of free curcumin was significantly higher than 
SICN, and it was continuously excreted, whereas SICN 
excretion was slower between 8 h and 24 h. Quantitative 
data in flow cytometry analysis (Figure 2F) showed the 
same consequence. It also showed that the spontaneous 
fluorescence of SICN could realize real-time monitoring at 
the cellular level.
Uptake and Release of SICN in Zebrafish
Zebrafish were chosen as an in vivo model for optical 
monitoring due to the model’s convenient optical imaging. 
Based on the spontaneous fluorescence of curcumin, SICN 
nanoparticles can also be self-monitored. This feature can 
monitor the uptake of SICN and curcumin in zebrafish in 
real-time. Zebrafish embryos were simply fed with curcu-
min/SICN and monitored using fluorescence imaging for 
72 h. As shown in Figures 3A, B and S7A, SICN and 
curcumin can be rapidly absorbed within 2 h by zebrafish, 
and then SICN was rapidly distributed in the whole body. 
In the first 4 h, SICN was absorbed in the liver and 
gastrointestinal tract. After 4 h, SICN was distributed in 
the whole body. As the drug was released and metabolized 
for a long time in vivo, its fluorescence could still be 
monitored until 72 h. In contrast, curcumin was only 
distributed in the gastrointestinal tract up to 4 h after 
being taken in and then distributed to the whole body 
and was gradually metabolized out of the body.
Real-time uptake experiments suggested that SICN can 
penetrate the tissue of a live zebrafish with ease. The death 
of zebrafish could not be observed in the effective dose of 
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Figure 2 In vitro real-time self-monitoring uptake and release of drugs. (A and B) In vitro flow cytometric analysis of fluorescent intensities of SICN (A) and curcumin (B) in 
HGC-27 cells at designated time intervals, it represents the uptake of SICN and curcumin. (C and D) In vitro flow cytometric analysis of fluorescent intensities in HGC-27 
cells at designated time intervals after SICN (C) and curcumin (D) were removed, it represents the excretion of SICN and curcumin. (E and F) Fluorescence quantitative 
data of SICN and curcumin in HGC-27 cells at designated time intervals (E for uptake and F for excretion). Data represent the mean ± SD, *Represents significant difference 
compared with control group (P<0.05), **Represents significant difference between irinotecan group and curcumin group (P<0.05).
submit your manuscript | www.dovepress.com                                                                                                                                                                                                                    
DovePress                                                                                                                                       
International Journal of Nanomedicine 2021:16 2492





































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Figure 3 In vivo imaging of zebrafish uptake and release of SICN and curcumin. (A and B) In vivo imaging of fluorescent intensities of SICN (A) and curcumin (B) in zebrafish at 
designated time intervals. (C and D) In vivo imaging of fluorescent intensities in zebrafish at designated time intervals after SICN (C) and curcumin (D) were removed.
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SICN. Therefore, it was boldly speculated that SICN 
might have the ability to penetrate the tissue at the whole 
organism level or even spread to all tissue regions without 
causing life-threatening side effects. Previous studies have 
also shown that SICN did not damage the main organs,23 
indicating that SICN can expand the scope of application 
and play a more extensive antitumor effect.
Similar to in vitro experiments, to monitor drug excre-
tion in the body, zebrafish were incubated with drugs for 4 
h and then cultured in fresh fish-water for observation. SICN 
was shown to be relatively stable and distributed throughout 
the zebrafish body within 8 h. Even at 18 h, there was 
a significant drug fluorescence distribution, and it was then 
gradually metabolized and excreted with time (Figure 3C). 
Conversely, curcumin stayed in the body for a short time and 
was metabolized and excreted quickly after the administra-
tion was stopped (Figures 3D and S7B). It has been proven 
that the longer the half-life of nanomedicine in the blood 
circulation is, the longer is the accumulation time of drugs in 
tumor tissues, which is conducive to enhance the role of 
enhanced permeability and retention (EPR) and reduce the 
frequency of taking drugs.27 Due to the long circulation of 
SICN in vivo, it has the potential to enhance the EPR effect.
Endocytosis and Intracellular Transport of 
SICN Nanoparticles
The frequently used method to determine the endocytic path-
ways of nanosystems is the use of pharmacological 
inhibitors.28,29 To track the internalization pathways of 
SICN nanoparticles, confocal microscopy is used to capture 
the fluorescence of SICN nanoparticles in cells pretreated 
with small-molecule endocytosis inhibitors. As shown in 
Figure 4A and B, the cellular uptake of SICN was signifi-
cantly blocked at 4°C, suggesting an energy-dependent inter-
nalization. Further, cellular uptake was significantly inhibited 
by cytochalasin D, methyl-β-cyclodextrin, wortmannin, and 
genistein (Figure 4C and D). Cytochalasin D and wortman-
nin are macropinocytosis inhibitors, genistein is a caveolin 
Figure 4 Fluorescence-based effects of inhibitors on the endocytosis of SICN nanoparticles on HGC-27 cells. (A) Cellular uptake of SICN nanoparticles at 37°C and 4°C 
environments as assessed by CLSM. (B) Data are mean ± standard deviation (SD). **p < 0.001, significant difference between normal and 4°C groups. (C) Cellular uptake of 
SICN nanoparticles in the absence (“without inhibitor” control) and presence of inhibitors, as assessed by CSLM. (D) Data are mean ± SD. **p < 0.001, significant difference 
between control and inhibitor groups. 
Abbreviation: NS, no statistical difference.
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inhibitor, and methyl-β-cyclodextrin simultaneously affects 
clathrin-mediated and independent endocytosis, indicating 
that SICN is internalized into gastric cancer cells through 
multiple pathways.
To further explore the distribution of SICN in cells 
after internalization, cells were stained with lysosomes 
and Golgi apparatus markers. As shown in Figure 5A 
and B, besides colocalization with lysosomes and Golgi 
apparatus, the fluorescence signal of SICN is almost dis-
tributed in the whole cytoplasm. Nanoparticles transported 
to lysosomes are easily metabolically inactivated, but most 
SICN can be delivered out of the cell in the form of 
original drugs or active ingredients through the Golgi 
apparatus and other channels and continuously act on the 
next cell, with the potential to penetrate deep into the 
tumor.
Cell Cytotoxicity
Human gastric cancer cells (HGC-27) were utilized to 
assess the cytotoxicity of irinotecan hydrochloride, 
SICN, curcumin. As shown in Figure 6A, the IC50 
value (half-maximal inhibitory concentration) of SICN 
nanoparticles against HGC-27 cells was 0.151 μM/L at 
the irinotecan hydrochloride equivalent and 0.481 μM/ 
L in irinotecan hydrochloride. Cytotoxicity of SICN 
nanoparticles against HGC-27 cells was slightly higher 
than irinotecan hydrochloride, with a significant differ-
ence (p < 0.05). Previous studies have confirmed that 
the conversional positive surface charges of SICN 
nanoparticles under acidic tumor environments and 
the negative surface charges under normal physiologi-
cal conditions make the acidic environment more likely 
to cause in vitro cytotoxicity than the alkaline 
environment.23 As shown in Figure 6C, the uptake of 
SICN by HGC-27 cells in a weak acid environment 
(pH 6.7) was increased by 68.5% compared to a weak 
alkaline environment (pH 7.5), and SICN showed 
stronger cytotoxicity to HGC-27 cells in a weak acid 
environment (Figure 6B). Due to the tunability of the 
surface charge of nanoparticles, it was more conducive 
for absorption by tumor cells in a weakly acidic tumor 
environment.
In order to provide more evidence for the cytotoxicity 
of SICN, we also used A2780 human ovarian cancer cells 
and A549 human non-small cell lung cancer cells to study 
the cytotoxicity of SICN (Figure S5). Similar to HGC-27 
cells, SICN shows strong cytotoxicity to A2780 cells and 
moderate cytotoxicity to A549 cells.
Figure 5 Intracellular trafficking of SICN in HGC-27 cells. Colocalization of SICN and Golgi-Tracker Red (A) or LysoTracker Red (B) after 6 h culture with HGC-27 cells.
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Cell Apoptosis
To investigate the cell death mechanism of SICN, HGC-27 
cells were double-labeled with Annexin V-FITC and PI 
before analysis by flow cytometry. Cell populations at dif-
ferent phases of cell death, namely, live (Q4), early apoptotic 
(Q3), late-stage apoptotic (Q2), and necrotic (Q1), at differ-
ent treatments are shown in the Figure 7. Compared to the 
control group (Figure 7A), there was no significant differ-
ence between the cell populations in the curcumin group 
(Figure 7B). In contrast, the percentage of total apoptotic 
cells (including early and late apoptosis) of the irinotecan 
hydrochloride (Figure 7C) and SICN nanoparticles groups 
(Figure 7D) dramatically increased to 35.6% and 60.2%, 
respectively, which were much more than the control group 
Figure 6 Cell cytotoxicity assays of irinotecan hydrochloride and SICN nanoparticles. (A) MTT assay curves of SICN, irinotecan hydrochloride and curcumin against HGC- 
27 cells for 48 h treatment (n = 3 independent experiments using the same batch of drugs). (B) MTT assay curves of SICN by changing the environmental pH values on HGC- 
27 cells. (C) The fluorescence intensity of SICN in A2780 cells detected by flow cytometry in different pH environments.
Figure 7 Apoptosis of HGC-27 cells induced by curcumin, irinotecan hydrochloride or SICN nanoparticles. (A) Control group, without treatment; (B) curcumin group; (C) 
irinotecan hydrochloride group; (D) SICN nanoparticles group; and (E) percentage of cell populations at different phases of the cell death.
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(2.77%). Both drugs caused late-stage apoptosis. The per-
centages of necrotic cells increased slightly to 3.62% and 
6.42%, which were higher than the control group (0.85%). 
More apoptotic and necrotic cells could be observed when 
cells were treated with SICN (Figure 7E). These results 
suggested that the designed nanoparticles were potential 
and effective strategy for apoptosis of HGC-27 cells.
Cell Cycle
PI was used to measure the cell DNA content. As shown in 
Figure 8A and B, treatment of HGC-27 cells with curcumin did 
not alter the cell cycle compared to the control group. Cells 
treated with irinotecan hydrochloride showed 55.0% arrest in 
the G2 phase of the cell cycle, leading to cell death (Figure 8C), 
compared to 5.8% in the control group. Nevertheless, cells 
treated with SICN exhibited a different block phase, which was 
arrest in the S phase at 65.8% (Figure 8D) compared to 28.5% 
in the control group. It can be clearly seen that SICN nanopar-
ticles caused DNA damage by blocking the S phase of DNA 
replication in HGC-27 cells (Figure 8E).
Conclusion
In summary, based on the established carrier-free nano-
systems of curcumin-irinotecan hydrochloride, the multi-
functional strategy of this anticancer combination 
therapy was further studied. Based on the fluorescence 
of curcumin, flow cytometry, zebrafish fluorescence ima-
ging, and confocal microscopy imaging indicated that 
SICN nanoparticles could be used as a real-time self- 
monitoring platform. It can monitor the uptake, absorp-
tion and excretion of nanoparticles in vivo and in vitro in 
real time. Meanwhile, it can also be used to study the 
internalization and intracellular transfer pathways of 
nanoparticles. Cytotoxicity experiments have shown 
that combination therapy leads to higher toxicity than 
single-component chemotherapy. Because nanoparticles 
can switch charge in a slightly acidic tumor environment, 
HGC-27 cells have more uptake of nanoparticles and 
higher toxicity under slightly acidic conditions. Overall, 
this multifunctional therapeutic strategy based on the 
carrier-free autofluorescent drug curcumin and irinotecan 
Figure 8 Cell cycle of HGC-27 cells induced by curcumin, irinotecan hydrochloride, or SICN nanoparticles. (A) Control group, without treatment; (B) curcumin group; (C) 
irinotecan hydrochloride group; (D) SICN nanoparticles group; and (E) percentage of cell populations at different phases of the cell cycle.
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hydrochloride to construct nanoparticles may open new 
ideas for combined cancer treatment and monitoring.
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